1 completed. 1 Phase 2, 1 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 1 | Completed 1 |
| Phase 3 | 1 | Completed 1 |
Follow Lipoatrophy: new trials by email Literature Review of Lipoatrophy trials Research Report on Lipoatrophy
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Effects of a Uridine Supplement on HIV Infected Adults With Lipoatrophy NucleomaxX, NucleomaxX placebo - HIV Infections, Lipoatrophy | Phase 2 / Phase 3 | Completed | National Institute of Allergy and Infectious Diseases (NIAID) | 167 | 2006-09-01 | 2021-11-04 |
HIV Infections (1) · Lipodystrophy (1)
Blood-Borne Infections (1) · Communicable Diseases (1) · Genital Diseases (1) · Immune System Diseases (1) · Immunologic Deficiency Syndromes (1) · Infections (1) · Lentivirus Infections (1) · Lipid Metabolism Disorders (1) · Metabolic Diseases (1) · Nutritional and Metabolic Diseases (1) · RNA Virus Infections (1) · Retroviridae Infections (1) · Sexually Transmitted Diseases (1) · Sexually Transmitted Diseases, Viral (1) · Skin Diseases (1)
National Institute of Allergy and Infectious Diseases (NIAID) (1)
Puerto Rico (1) · United States (1)
Grace A. McComsey, MD (1) · Judith A. Aberg, MD (1)